Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Sales (2016 - 2025)

Abeona Therapeutics has reported Return on Sales over the past 15 years, most recently at 3.77% for Q4 2025.

  • Quarterly results put Return on Sales at 3.77% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 13.4% (changed N/A YoY), and the annual figure for FY2025 was 12.23%, changed.
  • Return on Sales for Q4 2025 was 3.77% at Abeona Therapeutics, down from 222.92% in the prior quarter.
  • Over the last five years, Return on Sales for ABEO hit a ceiling of 972.27% in Q4 2021 and a floor of 192.85% in Q4 2022.
  • Median Return on Sales over the past 5 years was 5.98% (2025), compared with a mean of 70.96%.
  • Biggest five-year swings in Return on Sales: skyrocketed 97755bps in 2021 and later tumbled -116512bps in 2022.
  • Abeona Therapeutics' Return on Sales stood at 972.27% in 2021, then crashed by -120bps to 192.85% in 2022, then soared by 93bps to 13.59% in 2023, then decreased by -7bps to 14.48% in 2024, then soared by 74bps to 3.77% in 2025.
  • The last three reported values for Return on Sales were 3.77% (Q4 2025), 222.92% (Q3 2025), and 310.86% (Q2 2025) per Business Quant data.